Comparing robotic systems for kidney tumor surgery
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial compares different robotic platforms used to remove kidney tumors while saving healthy kidney tissue. It aims to see which system works best for patients with localized kidney tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 90 years old
- You have a kidney tumor that is still only in the kidney and can be removed with partial nephrectomy (surgery that saves the rest of the kidney)
- You are able to understand and sign a consent form
- You can commit to follow-up appointments after surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is comparing two different robotic systems (HUGO RAS and Da Vinci) used during surgery for prostate or kidney cancer. If you are scheduled for robot-assisted prostate removal or partial kidney removal, joining this study will help doctors see if one platform works better than the other.
This study compares two robotic surgery approaches for prostate and kidney cancer—one using a single small incision versus multiple small incisions. The goal is to see if one method works better, is safer, or helps patients recover faster.
This trial compares two robotic systems (Da Vinci and HUGO RAS) for surgery to treat deep endometriosis. If you have endometriosis that isn't helped by medicine and you need surgery, you may be able to join this study to see which robot works better.
This study looks at what happens when a kidney tumor accidentally breaks open during robotic surgery to remove part of the kidney. It aims to understand outcomes and help doctors and patients make better decisions.
This trial tests a new robotic system for removing kidney tumors up to 7 cm. It aims to see if the technology helps surgeons perform partial nephrectomy (removing only the tumor) safely and effectively.
This study compares a robot-assisted kidney-sparing surgery guided by 3D images. It aims to improve how precisely surgeons remove a complex kidney tumor while protecting kidney function.
Hear when a new Renal Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.